Autoimmune diseases companies

Companies whose enriched business profile is tagged “Autoimmune diseases”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• Roivant Sciences (ROIV) Health Care — Roivant Sciences is a biopharma company that accelerates drug development through a decentralized model of nimble, independent 'Vant' subsidiaries and proprietary computational tools. ask →
• SPYRE THERAPEUTICS INC (SYRE) Health Care — Spyre Therapeutics is developing next-generation, extended half-life antibodies and combination therapies aimed at redefining the standard of care for inflammatory bowel disease and immune-mediated conditions. ask →
• KINIKSA PHARMACEUTICALS INTERNATIO (KNSA) Health Care — Kiniksa is a biopharmaceutical company developing and commercializing therapies for chronic inflammatory and autoimmune diseases, with a pipeline featuring novel treatments for recurrent pericarditis. ask →
• DIANTHUS THERAPEUTICS INC (DNTH) Health Care — Dianthus Therapeutics is a clinical-stage biotechnology firm developing antibody-based complement inhibitors to treat severe autoimmune disorders. ask →
• AURINIA PHARMACEUTICALS INC (AUPH) Health Care — Aurinia Pharmaceuticals is a biopharmaceutical company commercializing LUPKYNIS, a targeted treatment for lupus nephritis. ask →
• VERA THERAPEUTICS INC CLASS A (VERA) Health Care — Vera Therapeutics is a commercial-stage biotech pioneer targeting B-cell-driven autoimmune diseases, currently focused on its lead BAFF/APRIL inhibitor for IgA nephropathy. ask →
• VIRIDIAN THERAPEUTICS ORS INC (VRDN) Health Care — A biopharmaceutical company commercializing therapies for thyroid eye disease and developing a pipeline of treatments for autoimmune and rare diseases. ask →
• AGIOS PHARMACEUTICALS INC (AGIO) Health Care — Agios Pharmaceuticals is a rare disease-focused biopharmaceutical company advancing a pipeline of novel hematology and genetic disorder therapies, anchored by its pyruvate kinase activator, mitapivat. ask →
• XENCOR INC (XNCR) Health Care — A clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines using its proprietary protein engineering platforms to treat cancer and autoimmune diseases. ask →
• JANUX THERAPEUTICS INC (JANX) Health Care — Janux Therapeutics is a clinical-stage biotech developing tumor-activated T-cell engagers and immunomodulators to treat cancer and autoimmune diseases with reduced toxicity. ask →
• FORTE BIOSCIENCES INC (FBRX) Health Care — A clinical-stage biopharmaceutical company focused on the development of novel therapies for dermatological and autoimmune conditions. ask →
• CULLINAN THERAPEUTICS INC (CGEM) Health Care — Cullinan Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of targeted therapies for cancer and autoimmune diseases. ask →
• JADE BIOSCIENCES INC (JBIO) Health Care — A clinical-stage biotechnology company developing innovative therapies for autoimmune and inflammatory diseases. ask →
• ANNEXON INC (ANNX) Health Care — Annexon is a clinical-stage biopharma company developing novel C1q-inhibitor therapies to treat neuroinflammatory and autoimmune diseases. ask →
• CLIMB BIO INC (CLYM) Health Care — Climb Bio is a clinical-stage biotech developing anti-CD19 monoclonal antibodies to treat immune-mediated diseases like lupus and nephropathy. ask →
• CABALETTA BIO INC (CABA) Health Care — Cabaletta Bio is a clinical-stage biotechnology company developing CARTA engineered T cell therapies intended to provide durable, potentially curative, one-time treatments for patients with a wide range of autoimmune diseases. ask →
• CENTURY THERAPEUTICS INC (IPSC) Health Care — Century Therapeutics is pioneering scalable, off-the-shelf allogeneic cell therapies using an iPSC-derived platform to treat autoimmune diseases and cancer. ask →
• CARTESIAN THERAPEUTICS INC (RNAC) Health Care — Cartesian Therapeutics is pioneering mRNA-engineered cell therapies designed to provide durable autoimmune disease treatment without the toxicity associated with conventional DNA-based CAR-T therapies. ask →
• NKARTA INC (NKTX) Health Care — Nkarta is a clinical-stage biotechnology company pioneering off-the-shelf, engineered natural killer (NK) cell therapies to treat autoimmune diseases by depleting pathogenic B cells. ask →
• Immunic, Inc. (IMUX) Health Care — Immunic is a late-stage biotechnology firm developing oral, small-molecule treatments for multiple sclerosis and other neurodegenerative diseases, led by its flagship candidate, vidofludimus calcium. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-10-08.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.